These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats. Zaniewska M; McCreary AC; Przegaliński E; Filip M Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403 [TBL] [Abstract][Full Text] [Related]
3. 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists. Millan MJ; Peglion JL; Lavielle G; Perrin-Monneyron S Eur J Pharmacol; 1997 Apr; 325(1):9-12. PubMed ID: 9151932 [TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated. Kennett GA; Trail B; Bright F Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683 [TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes. McCreary AC; Filip M; Cunningham KA Behav Neurosci; 2003 Apr; 117(2):212-21. PubMed ID: 12708517 [TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist. Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698 [TBL] [Abstract][Full Text] [Related]
8. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis. Hemrick-Luecke SK; Evans DC Neuropharmacology; 2002 Feb; 42(2):162-9. PubMed ID: 11804612 [TBL] [Abstract][Full Text] [Related]
10. 8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206,553. Millan MJ; Girardon S; Bervoets K Neuropharmacology; 1997; 36(4-5):743-5. PubMed ID: 9225301 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists. Batman AM; Munzar P; Beardsley PM Psychopharmacology (Berl); 2005 May; 179(2):393-401. PubMed ID: 15565434 [TBL] [Abstract][Full Text] [Related]
12. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors. Maura G; Marcoli M; Pepicelli O; Rosu C; Viola C; Raiteri M Br J Pharmacol; 2000 Aug; 130(8):1853-8. PubMed ID: 10952674 [TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats. Sánchez H; Velázquez-Martínez DN J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605 [TBL] [Abstract][Full Text] [Related]
14. Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. Hewitt KN; Lee MD; Dourish CT; Clifton PG Pharmacol Biochem Behav; 2002 Apr; 71(4):691-700. PubMed ID: 11888560 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS; Assié MB; Koek W J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338 [TBL] [Abstract][Full Text] [Related]
16. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808 [TBL] [Abstract][Full Text] [Related]
17. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Millan MJ; Dekeyne A; Gobert A Neuropharmacology; 1998 Jul; 37(7):953-5. PubMed ID: 9776391 [TBL] [Abstract][Full Text] [Related]
18. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Schreiber R; Brocco M; Millan MJ Eur J Pharmacol; 1994 Oct; 264(1):99-102. PubMed ID: 7530204 [TBL] [Abstract][Full Text] [Related]
19. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132 [TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice. Smith RL; Barrett RJ; Sanders-Bush E Psychopharmacology (Berl); 2003 Feb; 166(1):61-8. PubMed ID: 12474110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]